Literature DB >> 25256406

[Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling].

J Hübner1, M R Noftz, M Schnoor, A Katalinic.   

Abstract

The major goal of cancer screening programs is the reduction of disease-specific mortality by detecting malignant tumors in an early and still curable stage. Sensitive screening tests are used in apparently healthy people and conspicuous findings are referred for further investigations. Taking the personal disease risk into account, persons considering participation in a screening program should be informed about the methods, benefits and disadvantages of the screening program. This information, together with personal preferences, is the basis for a well-informed decision for or against participation in a screening program. This article imparts essential knowledge that is needed for individual medical counseling on screening for colorectal, skin, breast and prostate cancer.

Entities:  

Mesh:

Year:  2014        PMID: 25256406     DOI: 10.1007/s00108-014-3601-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  13 in total

Review 1.  Evidence for colorectal cancer screening.

Authors:  Michael Bretthauer
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-08       Impact factor: 3.043

Review 2.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].

Authors:  N Eisemann; A Waldmann; A Katalinic
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2014-01       Impact factor: 1.513

4.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

5.  Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.

Authors:  Alexander Katalinic; Annika Waldmann; Martin A Weinstock; Alan C Geller; Nora Eisemann; Ruediger Greinert; Beate Volkmer; Eckhard Breitbart
Journal:  Cancer       Date:  2012-04-19       Impact factor: 6.860

6.  Epidemiology of Breast Cancer - Current Figures and Trends.

Authors:  N Eisemann; A Waldmann; A Katalinic
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-02       Impact factor: 2.915

7.  Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.

Authors:  Annika Waldmann; Sandra Nolte; Alan C Geller; Alexander Katalinic; Martin A Weinstock; Beate Volkmer; Ruediger Greinert; Eckhard W Breitbart
Journal:  Arch Dermatol       Date:  2012-08

8.  Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Marco Zappa; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Liisa Määttänen; Hans Lilja; Louis J Denis; Franz Recker; Alvaro Paez; Chris H Bangma; Sigrid Carlsson; Donella Puliti; Arnauld Villers; Xavier Rebillard; Matti Hakama; Ulf-Hakan Stenman; Paula Kujala; Kimmo Taari; Gunnar Aus; Andreas Huber; Theo H van der Kwast; Ron H N van Schaik; Harry J de Koning; Sue M Moss; Anssi Auvinen
Journal:  Lancet       Date:  2014-08-06       Impact factor: 79.321

Review 9.  A systematic assessment of benefits and risks to guide breast cancer screening decisions.

Authors:  Lydia E Pace; Nancy L Keating
Journal:  JAMA       Date:  2014-04-02       Impact factor: 56.272

Review 10.  Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies.

Authors:  Hermann Brenner; Christian Stock; Michael Hoffmeister
Journal:  BMJ       Date:  2014-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.